EGFR is overexpressed in greater than 95% of HNSCC patient samples, and phosphorylation of the downstream effector Src kinase correlates with poorly differentiated HNSCC, lymph node involvement, and poor patient outcome [97,98,99]. Here, EGFR is linked to head and neck squamous cell carcinoma.